SKINMED® ENERPEEL® SALICYLIC ACID (SA)
SkinMed® EnerPeel® Salicylic Acid (SA)
SkinMed® EnerPeel® Salicylic Acid (SA) utilises 30% salicylic acid and is suspended in the patented EnerPeel® carrier solution.
This allows us to incorporate the SkinMed® Tebiskin® active ingredients in the carrier, which protects these ingredients from the blockage busting salicylic acid, enabling us to send a high strength, antibacterial and anti-inflammatory dose of OSK ingredients into the infected hair follicle to eradicate existing spots, oil and inflammation.
We combine this with our SkinMed® Retinoids and Ceramide Boosting Formulas to prevent spots happening in the first place. The SkinMed® Acne Protocol is medically indicated for Comedogenic and Inflammatory Acne and also NOW indicated for Resistant Acne (acne unresponsive to prescription medication for 12 months or more).
Acne – Causes and Symptoms
Hormonal sensitisation of the skin causes it to lose oils and fats (lipids), making the skin’s water loss increase dramatically, accelerating skin cell production, increasing keratin deposition inside cells, and pumping more oil onto the skin’s surface. Although these three things slow down the excessive water loss, the thickened skin and excess oil production combined with more dead skin cells narrow and closes the hair follicle openings. Bacteria which feed on oil migrate under skin blockages where they multiply, producing inflammatory by-products, resulting in the classic acne spot.
The science
Clinical studies were based at 5 university hospitals on patients whose resistant acne was defined as ‘unresolved’ – even after using prescription medication for 12 months. Patients were prescribed 4 EnerPeel® SA peels, 2 weeks apart in conjunction with the anti-acne topical regimen. This achieved an 84% resolution rate of their acne. This medical protocol kills 96% of acne bacteria, including all antibiotic-resistant acne bacteria, quickly and effectively.
EnerPeel®: Patented Carrier Technology
EnerPeel® uses a patented carrier solution which restrains the activity of the acid until it is absorbed. This is not buffering the acid and thereby reducing its activity; it is restraining it and then releasing it to accelerate through the skin. EnerPeel®s carrier system enhances its activity for uniform and enhanced absorption of the active ingredients; with two to three times improved skin penetration.
The Result
In clinical trials, an astounding 84% of difficult-to-treat patients found the products worked faster than antibiotics in reducing oil, bacterial infections and inflammation. The trials were conclusive and proved EnerPeel® SA, combined with SkinMed®’s Conplete Acne Protocol, to be more effective than the number one UK prescribed product without any associated side effects.
